Cargando…
Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer
BACKGROUND: Immune checkpoint blockade therapy with anti‐programmed cell death (PD)‐1 antibodies provides therapeutic effect for many patients of various cancers but remains inadequate in colorectal cancer (CRC) patients. The present study aims to assess the efficacy of oncolytic adenovirus (Onco(Ad...
Autores principales: | Huang, Lili, Zhao, Huaxin, Shan, Mengying, Chen, Hong, Xu, Bin, He, Yang, Zhao, Yu, Liu, Zhuqing, Chen, Jianhua, Xu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741988/ https://www.ncbi.nlm.nih.gov/pubmed/35762456 http://dx.doi.org/10.1002/cam4.4845 |
Ejemplares similares
-
Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer
por: Huang, Lili, et al.
Publicado: (2023) -
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021) -
Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
por: YANG, GUOHUA, et al.
Publicado: (2015) -
428 Development of an Oncolytic Adenovirus to Treat Metastatic Colorectal Cancer
por: LaRocca, Christopher J., et al.
Publicado: (2023) -
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)